tradingkey.logo
tradingkey.logo
검색

MiMedx Group Inc

MDXG
관심 목록에 추가
3.930USD
+0.120+3.15%
종가 06/26, 16:00ET시세는 15분 지연됩니다
582.01M시가총액
18.91P/E TTM

자세한 내용은 MiMedx Group Inc 회사

MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.

MiMedx Group Inc 정보

종목 코드 MDXG
회사 이름MiMedx Group Inc
상장일Aug 20, 2007
CEOCapper (Joseph H)
직원 수837
유형Ordinary Share
회계 연도 종료Aug 20
주소1775 W Oak Commons Court, Ne
도시MARIETTA
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호30062
전화17706519100
웹사이트https://mimedx.com/
종목 코드 MDXG
상장일Aug 20, 2007
CEOCapper (Joseph H)

MiMedx Group Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
310.29K
-190.25%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
284.25K
+28.78%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
263.68K
+19.31%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
--
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
108.51K
+46.92%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
93.15K
-28.52%
Mr. William Frank (Butch) Hulse, IV
Mr. William Frank (Butch) Hulse, IV
Chief Administrative Officer, General Counsel
Chief Administrative Officer, General Counsel
--
--
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. K. Todd Newton
Mr. K. Todd Newton
Independent Director
Independent Director
--
--
Marty Sutter ,
Marty Sutter ,
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
310.29K
-190.25%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
284.25K
+28.78%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
263.68K
+19.31%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
--
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
108.51K
+46.92%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
93.15K
-28.52%

자주 묻는 질문

MiMedx Group Inc의 상위 5대 주주는 누구인가요?

MiMedx Group Inc의 상위 5대 주주는 다음과 같습니다: Mr. Joseph H. (Joe) Capper

MiMedx Group Inc(MDXG)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, MiMedx Group Inc의 주식을 보유한 기관은 총 462곳이며, 이들이 보유한 주식의 총 가치는 약 116.77M로 전체 발행 주식의 78.40%를 차지합니다. 이는 2025Q4 대비 6172968.00 증가한 수치입니다.

MiMedx Group Inc의 최대 수익원은 무엇인가요?

2026Q1 기준, MiMedx Group Inc의 Advanced Wound Care 부문이 가장 높은 매출을 기록했으며, 금액은 276.33M로 전체 매출의 66.01%를 차지했습니다.
KeyAI